Literature DB >> 18766152

FDG-PET analysis of amygdalar-cortical network covariance during pre- versus post-menopausal estrogen levels: potential relevance to resting state networks, mood, and cognition.

William E Ottowitz1, David Derro, Darin D Dougherty, Martin A Lindquist, Alan J Fischman, Janet E Hall.   

Abstract

OBJECTIVES: 1.) Expand the scope of neuroendocrine applications of functional neuroimaging techniques. 2.) Compare the covariance of amygdalar activity with that of the rest of the brain during pre- and post-menopausal levels of estrogen (E2). Based on the distribution of cortical E2 receptors and the neocortical regions where E2 has been shown to preferentially accumulate, we predict that E2 infusion will increase covariance of amygdalar activity with that of the temporal and frontal cortices.
DESIGN: This basic physiology study employed a within-subject design. All participants were post-menopausal women (n =7). Analysis of covariance between whole brain and amygdalar regional cerebral glucose consumption (CMRglc) was conducted in a voxel-wise manner by means of the basic regression option in SPM2 and was applied to FDG-PET scans acquired at baseline and after a 24 hour graded E2 infusion.
SETTING: An academic medical center; Massachusetts General Hospital, Boston, Massachusetts.
RESULTS: E2 levels (mean +/- sem) were significantly greater at 24 hours (257.9 pg/mL +/- 29.7) than at 0 hours (28.1 pg/mL +/- 3.4). Right amygdalar CMRglc showed a significant covariance with activity of three different regions of the temporal cortex during E2 infusion, but none at baseline. In addition, right amygdalar CMRglc covaried with that of the right medial and superior frontal gyri only during E2 infusion.
CONCLUSIONS: In addition to suggesting changes in amygdalar-cortical network connectivity as a result of short-term E2 exposure, these analyses provide evidence that basic neuroendocrine research may benefit from further use of FDG-PET and other functional neuroimaging modalities for network level analyses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18766152      PMCID: PMC3947844     

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  45 in total

1.  Cortical networks for working memory and executive functions sustain the conscious resting state in man.

Authors:  B Mazoyer; L Zago; E Mellet; S Bricogne; O Etard; O Houdé; F Crivello; M Joliot; L Petit; N Tzourio-Mazoyer
Journal:  Brain Res Bull       Date:  2001-02       Impact factor: 4.077

2.  Immunolocalisation of oestrogen receptor beta in human tissues.

Authors:  A H Taylor; F Al-Azzawi
Journal:  J Mol Endocrinol       Date:  2000-02       Impact factor: 5.098

Review 3.  Dendritic spine plasticity in hippocampus.

Authors:  A Gazzaley; S Kay; D L Benson
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 4.  What is the amygdala?

Authors:  L W Swanson; G D Petrovich
Journal:  Trends Neurosci       Date:  1998-08       Impact factor: 13.837

5.  Extracellular adenosine triphosphate affects neural cell adhesion molecule (NCAM)-mediated cell adhesion and neurite outgrowth.

Authors:  G Skladchikova; L C Ronn; V Berezin; E Bock
Journal:  J Neurosci Res       Date:  1999-07-15       Impact factor: 4.164

6.  Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells.

Authors:  N D'Ambrosi; B Murra; F Cavaliere; S Amadio; G Bernardi; G Burnstock; C Volonté
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

7.  Hydrocortisone induced regional cerebral activity changes in schizophrenia: a PET scan study.

Authors:  Rohan Ganguli; Amitabh Singh; Jaspreet Brar; Cameron Carter; Mark Mintun
Journal:  Schizophr Res       Date:  2002-08-01       Impact factor: 4.939

8.  Estradiol and testosterone in specific regions of the human female brain in different endocrine states.

Authors:  M Bixo; T Bäckström; B Winblad; A Andersson
Journal:  J Steroid Biochem Mol Biol       Date:  1995-12       Impact factor: 4.292

9.  Oestrogen infusions into the amygdala potentiate excitatory transmission from the accessory olfactory bulb to tuberoinfundibular arcuate neurones in the mouse.

Authors:  C S Li; H Kaba; H Saito; K Seto
Journal:  Neurosci Lett       Date:  1992-08-31       Impact factor: 3.046

10.  Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women.

Authors:  A E Taylor; H Whitney; J E Hall; K Martin; W F Crowley
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

View more
  5 in total

1.  Hormonal Cycle and Contraceptive Effects on Amygdala and Salience Resting-State Networks in Women with Previous Affective Side Effects on the Pill.

Authors:  Jonas Engman; Inger Sundström Poromaa; Lena Moby; Johan Wikström; Mats Fredrikson; Malin Gingnell
Journal:  Neuropsychopharmacology       Date:  2017-06-25       Impact factor: 7.853

Review 2.  Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Authors:  Jia Yao; Roberta Diaz Brinton
Journal:  Adv Pharmacol       Date:  2012

3.  Increased functional connectivity with puberty in the mentalising network involved in social emotion processing.

Authors:  Eduard T Klapwijk; Anne-Lise Goddings; Stephanie Burnett Heyes; Geoffrey Bird; Russell M Viner; Sarah-Jayne Blakemore
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

Review 4.  Sex steroid hormones and brain function: PET imaging as a tool for research.

Authors:  R Moraga-Amaro; A van Waarde; J Doorduin; E F J de Vries
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

5.  High body mass index, brain metabolism and connectivity: an unfavorable effect in elderly females.

Authors:  Arianna Sala; Maura Malpetti; Anna Ferrulli; Luigi Gianolli; Livio Luzi; Daniela Perani
Journal:  Aging (Albany NY)       Date:  2019-10-09       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.